Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3341 of 6351
-
Ozone shots for thumb arthritis: a new hope?
Symptom relief CompletedOsteoarthritis of trapezio-metacarpal joint (TMJ) most commonly occurs in women over 50 years old, often bilateral and it is a disabling condition presenting with pain at base of the thumb, swelling, instability, deformity and impairment of hand function with limitation in grippi…
Phase 3 • Sponsor: Humanitas Clinical and Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New combo therapy aims to shrink eye tumors before radiation
Disease control By invitation onlyThe goal of this clinical trial is to investigate a new approach for treating large uveal melanomas, a type of eye cancer. The study aims to determine the effectiveness of using intra-arterial melphalan, a chemotherapy drug, to reduce tumor thickness, allowing for subsequent radi…
Phase 1/2 • Sponsor: Hospital das Clínicas de Ribeirão Preto • Aim: Disease control
Last updated Jun 26, 2026 17:03 UTC
-
Brain scans reveal how reading rewires dyslexic Kids' brains
Knowledge-focused CompletedDyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging methods, in combination with reading education programs, to generate a new unde…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Liver cancer drug combo shows different results in different organs
Knowledge-focused CompletedHepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-related deaths globally and in Korea. Many patients diagnosed at advanced stage, and systemic therapy is mainstay of treatment in patients with advanced HCC. However, immune-checkpoint inhibitor (ICI) mo…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Blood test may spot CTE in living patients for first time
Knowledge-focused CompletedIn this study, high-throughput screening and multi-omics (transcriptomics and proteomics) joint analysis technology will be employed to explore potential CTE/TES biomarkers (RNA and protein) in blood and its exosomes. Thereafter, these biomarkers will be combined with the reporte…
Sponsor: Tianjin Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Laser or shock waves: which eases stroke spasticity better?
Symptom relief CompletedStroke is one of the leading causes of long-term disability worldwide. Spasticity (muscle spasm) is a common and disabling consequence of stroke. Lower extremity spasticity significantly compromises postural control, balance, and gait performance. Patients with spasticity demonst…
Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Scientists hunt for molecules that predict spinal cord healing
Knowledge-focused CompletedThis study main aim is to identify molecular determinants of better recovery following spinal cord injury (SCI), as biomarkers of neurological and/or functional improvement and a proxy for neuroregeneration. For that, omics analyses of several biological samples will be performed…
Sponsor: Prof. Sandra Vieira • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Laser therapy shows promise for chronic Bell's palsy
Symptom relief CompletedOBJECTIVE: To determine whether photobiomodulation therapy by class IV Multiwave Locked System laser treatment could relieve symptoms in patients with Bell's palsy with a duration of greater than 8 weeks. METHODS AND METHODS: This randomized controlled trial from May 2021 to Apr…
Sponsor: Beijing Tongren Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can simple dietary advice slash your sugar intake?
Disease control CompletedThis randomised controlled trial aims to assess the impacts of the current recommendations by Public Health England for reducing free sugar intakes, on total energy intakes of free sugar in a sample of the UK population.
Sponsor: Bournemouth University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New lung support device shows promise for ARDS patients
Disease control CompletedPrismaLung+ is intended to provide extracorporeal carbon dioxide removal (ECCO2R) as a standalone therapy or in combination with continuous renal replacement therapy (CRRT). This study is a multi-centre, prospective, open-label, single-arm study. Adult patients with mild or moder…
Sponsor: Vantive Health LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThe primary purpose of this study is to assess the safety and tolerability of lunresertib alone and in combination with RP-3500 or in combination with Debio 0123 in patients with eligible advanced solid tumors, determine the maximum tolerated dose (MTD) and assess preliminary ant…
Phase 1 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New study reveals how diabetes drug semaglutide may protect kidneys
Knowledge-focused CompletedWe are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doing this by looking into how semaglutide works in the kidneys. Participants will either get semaglutide or placebo (a 'dummy' medicine) - wh…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Could an extra stitch save Kids' ACL repairs? new trial aims to find out
Disease control Recruiting nowThe overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody combo aims to tame rare blood disease
Disease control OngoingThis phase I trial studies the side effects of isatuximab and to see how well it works in treating patients with high risk immunoglobulin light chain amyloidosis (AL amyloidosis). Isatuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and s…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Warm eyelid treatment could replace daily drops for dry eye sufferers
Symptom relief CompletedTo demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult patients.
Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Experimental cocktail targets tough lung cancer
Disease control CompletedThis phase I trial seeks to find out the best dose, possible benefits and/or side effects of entinostat in combination with atezolizumab, carboplatin and etoposide for the treatment of previously untreated aggressive lung cancer that has spread (extensive-stage small cell lung ca…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New online training helps nursing home staff calm Dementia-Related behaviors
Symptom relief CompletedThe National Plan to Address Alzheimer's disease has identified education of dementia care providers as a top priority to address the need for quality care for the population of persons with dementia that will triple in the next 30 years. This study will test new online interacti…
Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New brain scan reveals how DBS rewires Parkinson's patients' brains
Knowledge-focused CompletedDeep brain stimulation of the subthalamic nucleus (STN DBS) in Parkinson's disease (PD) can provide substantial motor benefit yet can also produce unwanted mood and cognitive side effects. Although the neural mechanisms underlying benefits and side effects are not well understood…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Lung cancer immunotherapy cocktail shows promise but trial halted early
Disease control Stopped earlyThis study will evaluate the surgical safety and feasibility of atezolizumab plus tiragolumab alone or in combination with platinum-based chemotherapy as neoadjuvant treatment for participants with previously untreated locally advanced non-small cell lung cancer (NSCLC). The stud…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Which suicide prevention method works best? new study aims to find out.
Knowledge-focused OngoingParticipants will be randomly assigned to 1 of the 4 interventions using a sequential stratified randomization procedure. We will use sex (M, F) and history of suicide attempts (never, 1, and multiple) as our randomization strata. Participants will be assessed before and after th…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC